Your search returned 9 results.

Results
	1.	Risk of disease flare with LHRH agonist therapy in men with prostate cancer: myth or fact? [electronic resource] by Vis, André N van der Sluis, Tim M Al-Itejawi, Hoda H M van Moorselaar, R Jeroen A Meuleman, Eric J H Producer: 20160210 In: Urologic oncology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer. [electronic resource] by van der Sluis, Tim M Vis, André N van Moorselaar, R Jeroen A Bui, Hong N Blankenstein, Marinus A Meuleman, Eric J H Heijboer, Annemieke C Producer: 20120221 In: BJU international vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer. [electronic resource] by van der Sluis, Tim M Meuleman, Eric J H van Moorselaar, R Jeroen A Bui, Hong N Blankenstein, Marinus A Heijboer, Annemieke C Vis, André N Producer: 20120221 In: BJU international vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Relationship between body mass index and serum testosterone concentration in patients receiving luteinizing hormone-releasing hormone agonist therapy for prostate cancer. [electronic resource] by van der Sluis, Tim M van Moorselaar, R Jeroen A Meuleman, Eric J H ter Haar, Ronald W Bui, Hong N Heijboer, Annemieke C Vis, André N Producer: 20130618 In: Urology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer. [electronic resource] by van der Sluis, Tim M Bijnsdorp, Irene V Jacobs, John J L Meuleman, Eric J H Rozendaal, Lawrence Geldof, Albert A van Moorselaar, R Jeroen A Vis, André N Producer: 20131022 In: World journal of urology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Surgical Outcomes of Neoscrotal Augmentation with Testicular Prostheses in Transgender Men. [electronic resource] by Pigot, Garry L S Al-Tamimi, Muhammed Ronkes, Brechje van der Sluis, Tim M Özer, Müjde Smit, Jan Maerten Buncamper, Marlon E Mullender, Margriet G Bouman, Mark-Bram van der Sluis, Wouter B Producer: 20200706 In: The journal of sexual medicine vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry. [electronic resource] by van der Sluis, Tim M Bui, Hong N Meuleman, Eric J H Heijboer, Annemieke C Hartman, Jeroen F van Adrichem, Nick Boevé, Egbert de Ronde, Willem van Moorselaar, R Jeroen A Vis, André N Producer: 20130708 In: The Journal of urology vol. 187 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy. [electronic resource] by Jansen, Bernard H E van Leeuwen, Pim J Wondergem, Maurits van der Sluis, Tim M Nieuwenhuijzen, Jakko A Knol, Remco J J van Moorselaar, Reindert J A van der Poel, Henk G Oprea-Lager, Daniela E Vis, André N Producer: 20220201 In: European urology oncology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. [electronic resource] by van den Eertwegh, Alfons J M Versluis, Jurjen van den Berg, H Pieter Santegoets, Saskia J A M van Moorselaar, R Jeroen A van der Sluis, Tim M Gall, Helen E Harding, Thomas C Jooss, Karin Lowy, Israel Pinedo, Herbert M Scheper, Rik J Stam, Anita G M von Blomberg, B Mary E de Gruijl, Tanja D Hege, Kristen Sacks, Natalie Gerritsen, Winald R Producer: 20120626 In: The Lancet. Oncology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)